The effect of Saccharomyces boulardii on reducing irinotecan-induced intestinal mucositis and diarrhea

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

J-Y Douillard, David Cunningham, AD Roth et al. · The Lancet · 2000 · 3.3K citations

Medicine, Pharmacology, Colorectal Cancer +6

Phenotypically distinct subsets of CD4⁺ T cells induce or protect from chronic intestinal inflammation in C. B-17 <i>scid</i> mice

Fiona Powrie, Michael W. Leach, Smita Mauze et al. · International Immunology · 1993 · 1.1K citations

A Randomized Placebo-Controlled Trial of Saccharomyces boulardii in Combination With Standard Antibiotics for Clostridium difficile Disease

Lynne V. McFarland · JAMA · 1994 · 854 citations

Saccharomyces boulardii in Maintenance Treatment of Crohn’s Disease

Mario Guslandi, G. Mezzi, M. Sorghi et al. · Digestive Diseases and Sciences · 2000 · 712 citations

Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer

Nasser H. Hanna, Paul A. Bunn, Corey J. Langer et al. · Journal of Clinical Oncology · 2006 · 673 citations · Full text